Andrew Curtis, a former Pfizer Inc executive and entrepreneur, has joined Affimed NV as head of corporate strategy and business development. Affimed is developing bispecific antibodies for cancer. At Pfizer, Mr Curtis led the company’s speciality care business teams and was involved in crafting strategy for ‘open innovation.’ He has also been chief executive of Jerini US Inc (Shire), which developed a treatment for hereditary angioedema. Mr Curtis holds a BA from Muhlenberg College and an MA from Lehigh University, both in the US.
Affimed announced the appointment on 2 December 2015.
Copyright 2015 Evernow Publishing Ltd